Business Description
ZYUS Life Sciences Corp
NAICS : 325412
SIC : 3741
ISIN : CA9899601095
Compare
Compare
Traded in other countries / regions
ZYUS.CanadaZLSCF.USA IPO Date
2023-08-16Description
ZYUS Life Sciences Corp is primarily engaged in the global development and commercialization of innovative cannabinoid-based therapeutics and product candidates. It is a licensed producer and distributor of medical cannabis for both medical and adult recreational access in Canada.
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.26 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.49 | |||||
Debt-to-EBITDA | -0.25 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | -6.78 | |||||
Beneish M-Score | -0.44 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56.32 | |||||
9-Day RSI | 50.24 | |||||
14-Day RSI | 47.38 | |||||
6-1 Month Momentum % | 25.92 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.49 | |||||
Quick Ratio | 0.31 | |||||
Cash Ratio | 0.2 | |||||
Days Inventory | 5762.09 | |||||
Days Sales Outstanding | 393.48 | |||||
Days Payable | 10482.34 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 36.14 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 46.25 | |||||
Operating Margin % | -3960.72 | |||||
Net Margin % | -11366.93 | |||||
FCF Margin % | -4966.55 | |||||
ROE % | -156.02 | |||||
ROA % | -74.15 | |||||
ROIC % | -25.64 | |||||
ROC (Joel Greenblatt) % | -287.21 | |||||
ROCE % | -95.44 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 171.57 | |||||
PB Ratio | 3.6 | |||||
Price-to-Tangible-Book | 72 | |||||
EV-to-EBIT | -1.81 | |||||
EV-to-EBITDA | -1.94 | |||||
EV-to-Revenue | 200.62 | |||||
EV-to-Forward-Revenue | 187.57 | |||||
EV-to-FCF | -4.09 | |||||
Earnings Yield (Greenblatt) % | -55.25 | |||||
FCF Yield % | -27.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ZLSCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ZYUS Life Sciences Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.287 | ||
EPS (TTM) ($) | -0.598 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 47.38 | ||
14-Day ATR ($) | 0.012666 | ||
20-Day SMA ($) | 0.727495 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 0.56 - 0.81 | ||
Shares Outstanding (Mil) | 70.85 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ZYUS Life Sciences Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ZYUS Life Sciences Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
ZYUS Life Sciences Corp Frequently Asked Questions
What is ZYUS Life Sciences Corp(ZLSCF)'s stock price today?
The current price of ZLSCF is $0.72. The 52 week high of ZLSCF is $0.81 and 52 week low is $0.56.
When is next earnings date of ZYUS Life Sciences Corp(ZLSCF)?
The next earnings date of ZYUS Life Sciences Corp(ZLSCF) is .
Does ZYUS Life Sciences Corp(ZLSCF) pay dividends? If so, how much?
ZYUS Life Sciences Corp(ZLSCF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |